NIH Small Research Grant Program (Parent R03) (PA-18-488)

Ethical, Legal and Social Implications Program
Bettie J. Graham, Ph.D. 
Phone: (301) 496-7531
E-mail: bettie_graham@nih.gov

The National Human Genome Research Institute (NHGRI) uses the Small Grant (R03) mechanism to support research on the ethical, legal, and social implications (ELSI) of genetic and genomic research.  A more detailed discussion of the high priority research areas covered by this announcement can be found on the NHGRI ELSI Program website: http://www.genome.gov/page.cfm?pageID=10001618. 

With respect to the ELSI program, the R03 mechanism is designed to:

• encourage the development of small, focused research projects by legal, historical, ethics, humanities, social sciences and behavioral scholars;
• support exploratory studies that may provide preliminary findings or pilot data for larger research proposals;
• support the secondary analysis of existing data;
• support the development of new methodologies; and
• stimulate and facilitate the entry of promising new investigators into ELSI Research

For research applications with direct costs greater than $50,000 a year, or with a project period exceeding 2 years, applicants should refer to the NHGRI ELSI Regular Research Grant (R01) program announcement.  PA-04-050

Prospective applicants may also wish to read “A Vision for the Future of Genomics Research”(http://www.nhgri.nih.gov/11006873) to familiarize themselves with the research interests of the Institute.

Robin A. Barr, D. Phil.
Phone: 301-496-9322
FAX: 301-402-2945
E-mail: BarrR@mail.nih.gov 

The National Institute on Aging (NIA) will accept investigator-initiated small research projects (R03) for all program areas supported by the Institute. These will be reviewed by CSR. Please consult our Web site, http://www.nia.nih.gov/GrantsAndTraining/Funding
Opportunities/ResearchProjects.htm#r03, for information regarding specific programmatic priorities and other information. See Funding Opportunities for more information and to view NIA's primary or secondary sponsor announcements.

Division of Epidemiology and Prevention Research 
Gregory Bloss
Phone: 301-443-3865
FAX: 301-443-8614
E-mail: gbloss@mail.nih.gov

Division of Medications Development Research 
Joanne B. Fertig, Ph.D.
Phone: 301-443-0635
FAX: 301-443-8774
E-mail: jfertig@mail.nih.gov

Division of Metabolism and Health Effects 
Dale Hereld, M.D., Ph.D.
Phone: 301-443-0912
FAX: 301-594-0673
E-mail: hereldd@mail.nih.gov

Division of Neuroscience and Behavior
John Matochik, Ph.D.
Phone: 301-451-7319
FAX: 301-443-1650
E-mail: jmatochi@mail.nih.gov

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) will accept investigator-initiated research projects using the R03 mechanism for all areas of alcohol research, particularly those defined as NIAAA special emphasis areas. The Institute's mission statement, extramural research program descriptions, list of special emphasis areas, and active program announcements may be found at the NIAAA web site: http://www.niaaa.nih.gov.

The NIAAA R03 program provides limited support for exploring the feasibility of innovative or creative research questions within the research interests of the NIAAA. This includes basic and applied research on biochemical, physiological, genetic, and behavioral mechanisms leading to pathological drinking behavior; mechanisms of alcohol-induced organ damage, including fetal injury; and clinical, behavioral, and epidemiological approaches to more effective diagnosis, prevention, and treatment of alcoholism, alcohol abuse and alcohol-related problems. While applications may involve a wide variety of biomedical, behavioral, clinical, sociocultural, or other disciplines, relevance to the mission of the NIAAA must be clear.

To obtain more information about existing NIAAA program areas and the corresponding program administrators for R03 awards, please refer to the NIAAA extramural website at http://www.niaaa.nih.gov/research/extramural-research.

Conrad Mallia, Ph.D.
Division of Allergy, Immunology, and Transplantation (DAIT)
Phone: 240-627-3491
E-mail: cmallia@niaid.nih.gov​

Madelon Halula, PhD
Division of AIDS (DAIDS)
Phone: 240-292-4843    
Email: mhalula@niaid.nih.gov

Clayton Huntley, PhD
Division of Microbiology and Infectious Diseases (DMID)
Phone:  240-627-3279
Email: chuntley@niaid.nih.gov

For general information about NIAID support of R03 applications, e-mail NIAIDReceiptReferral@niaid.nih.gov

The National Institute of Allergy and Infectious Diseases (NIAID) will accept investigator-initiated R03 applications for all program areas supported by the Institute, but will not accept R03 applications that include clinical trials. For more information on NIAID's policy regarding clinical trials, see /grants/guide/notice-files/NOT-AI-16-084.html.

For information on NIAID R03 research opportunities in Biodefense, please see http://www.niaid.nih.gov/topics/BiodefenseRelated/Biodefense/research/.

Tatjana Atanasijevic, Ph.D.
Phone: 301-451-6873
E-mail: atanasijevict@nih.gov

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is interested in research applications that are focused on the development and application of new biomedical technologies. The Institute encourages the integration of engineering, the physical sciences and the life sciences to advance human health. For a description of the scientific research programs in the NIBIB please see http://www.nibib.nih.gov/Research/ProgramAreas  Please contact us if you have questions regarding the Institute’s interest in your research.

NICHD supports research activities within its mission, including normal and abnormal human development, male and female fertility and infertility, developing and evaluating contraceptive methods, pregnancy, childbirth, prenatal and postnatal development, childhood development through adolescence, and rehabilitation research.  NICHD develops, implements, and coordinates cross-cutting, multidisciplinary research in areas such as improving the safety and efficacy of pharmaceuticals for use in pregnant women, infants, and children; HIV infection and transmission, AIDS, and associated infections; pediatric growth and endocrine research; child development and behavior; developmental biology and typical and atypical development; intellectual and developmental disabilities; gynecologic health conditions, including pelvic floor disorders; childhood injury and critical illness; medical rehabilitation; and demography, social sciences, and population dynamics.

Additional information about NICHD research interests may be found at: http://www.nichd.nih.gov/grants-funding/opportunities-mechanisms/areas-research/Pages/default.aspx

Program staff contacts may be found on the web pages for NICHD's scientific branches at: http://www.nichd.nih.gov/about/org/der/branches/Pages/index.aspx and http://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx

Tracy Waldeck, Ph.D.
Phone: 301-827-5844
Email: tracy.waldeck@nih.gov

The National Institute on Drug Abuse (NIDA) uses the Small Grant (R03) mechanism to provide support for projects requiring minimal funding for limited periods of time in any area relevant to the mission of the Institute as represented by its program areas. Examples of the types of projects supported by NIDA through the small grant mechanism include: Pilot or feasibility studies; development of research methodology; applied research; high risk/high payoff studies; development of new research technology; small-scale, self-contained projects; and analysis of existing datasets.

Thaddeus Schug Ph.D.
Phone: 984-287-3319
FAX: 919-541-5054
E-mail: schugt@niehs.nih.gov

The National Institute of Environmental Health Sciences (NIEHS) will accept investigator-initiated research projects using the R03 mechanism for all areas of environmental health science research; particularly those defined as NIEHS special emphasis areas. Details on these areas can be found at http://www.niehs.nih.gov/research/supported/programs/. To obtain more information about existing NIEHS program areas and their corresponding program administrators, please refer to the NIEHS extramural website at http://www.niehs.nih.gov/funding/grants/contacts.cfm.  Investigators should direct scientific questions concerning the use of R03s to the appropriate program administrator responsible for the scientific area proposed.

NIMH Program Staff contacts Inquiries may be directed to NIMHReferral@mail.nih.gov. Also, see Division web pages (below)

The National Institute of Mental Health (NIMH) uses the Small Grant (R03) mechanism to provide support for projects requiring minimal funding for limited periods of time in any area relevant to the mission of the Institute as represented by its program areas:

• Division of Neuroscience and Basic Behavioral Science (DNBBS):  Supports research programs in basic neuroscience, genetics, basic behavioral science, research training, resource and technology development and drug discovery.
• Division of Adult Translational Research and Treatment Development (DATR): Supports translational research on the mechanisms of adult psychopathology and the development of novel treatment approaches for adult mental disorders.
• Division of Developmental Translational Research (DDTR): Supports integrated research and research training that translates knowledge from basic/behavioral science into a better understanding of pediatric psychopathology and the development of novel treatment and prevention strategies.
• Division of AIDS Research (DAR): Supports research on behavioral strategies to stop the spread of HIV/AIDS and research on the mental health effects of HIV/AIDS.
• The Division of Services and Intervention Research (DSIR): Supports research that evaluates the effectiveness of treatment and preventive mental health interventions and mental health services research.

Examples of the types of projects supported by NIMH through the small grant mechanism include: pilot or feasibility studies; development of research methodology; high risk studies; development of new research technology; small-scale, self-contained projects; and analysis of existing data sets.

Rina Das, PhD
Phone: 301-496-3996
Email: dasr2@mail.nih.gov

The National Institute on Minority Health and Health Disparities (NIMHD) will accept investigator-initiated small research projects (R03) for all program areas supported by the Institute. For further information on NIMHD investigator-initiated minority health and health disparities research, please see http://www.nimhd.nih.gov/programs/extra/iir.pdf.

Karrah Benson
National Institute of Neurological Disorders and Stroke(NINDS)
Phone: 301-496-0838
Email: karrah.benson@nih.gov
 

The National Institute of Neurological Disorders and Stroke (NINDS) uses the Small Grants Program (R03) to provide research support for new research projects in areas of high relevance to the mission of the NINDS (http://www.ninds.nih.gov/about_ninds/ninds_overview.htm). Priority will be given to applications in any of the following categories:

• Research projects leading to a defined product, resource or "deliverable" that has inherent value to the neuroscience community. Some examples include: creation of new animal models (e.g., mouse genetic models), generation of reagents (e.g., antibodies, RNAi, affinity capture reagents for use in a protein chip microarray), development of public resources (e.g., databases), development of cellular models for neurological disorders, development of novel phenotypic or behavioral screens for models of neurological disorders.
• Research projects that, regardless of whether they are hypothesis-driven, will generate an important and potentially publishable unit of information or dataset (either by itself or in combination with other data). Such projects should utilize a well-designed model of the normal or diseased nervous system. Some examples include: microarray gene expression analyses, proteomic analyses, pre-clinical drug screens.
• Research projects focused on secondary analysis of clinical data sets. This mechanism could also be appropriate for the collection of samples and/or associated clinical data to be included in the NINDS Genetics Repository (see: http://ccr.coriell.org/Sections/Collections/NINDS/?SsId=10).

Priority will be given to research proposals that include a detailed plan for the sharing of resources and data generated under this award. Potential applicants are advised to contact program staff to verify that the proposed research is relevant to NINDS and responsive to one of the listed criteria. A complete listing of program director contacts may be found at: http://www.ninds.nih.gov/about_ninds/organization.htm#Extramural

Investigators are encouraged to contact an NCCAM staff member in the Division of Extramural Research for assistance with submitting a grant application.

Each Program Officer is responsible for coordinating different scientific research portfolios.  Specific contact information can be found at: http://nccam.nih.gov/research/contact/index.htm

The National Center on Complementary and Alternative Medicine (NCCAM) will not accept R03 applications in response to the Parent R03 FOA. NCCAM uses the R03 mechanism only when specified in specific PAs or RFAs that it has initiated or in which it participates.

Christopher L. Hatch, Ph.D.
Phone:  301-496-3428
FAX: 301-402-0275
Email: ch29v@nih.gov

The National Cancer Institute (NCI) will NOT accept unsolicited R03s. The NCI will use the R03 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. The currently active announcements are listed on the NCI website at: http://deainfo.nci.nih.gov/funding.htm.

Valerie L Prenger, Ph.D.
Phone: 301-435-0270
FAX: 301-480-0730
Email: prengerv@nhlbi.nih.gov
 

The National Heart, Lung, and Blood Institute (NHLBI) will NOT accept R03 applications in response to the Parent R03 FOA. The NHLBI will use the R03 mechanism only when specified by specific FOAs that it has initiated or in which it participates.

Su-Yau Mao, Ph.D.
Phone: 301-594-5032
FAX: 301-480-1284
Email: maos2@mail.nih.gov

The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) will not accept investigator initiated R03 applications. The NIAMS will use the R03 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. Current active announcements using the R03 mechanism is listed on the NIAMS website at: https://www.niams.nih.gov/grants-funding/funding-opportunities/search?text_search=R03#/​

Dr. Bracie Watson
Phone: 301- 402-3458
Email: Watsonb@nidcd.nih.gov

The National Institute on Deafness and Other Communication Disorders (NIDCD) will not accept investigator initiated R03 applications but will continue to announce our very specific R03 program on a regular basis as a PAR. The currently active announcement is listed on the NIDCD web site at: http://www.nidcd.nih.gov/funding/types/pages/researchgrants.aspx#R03. 

For further information about the NIDCD R03 program contact Dr. Bracie Watson, 301-402-3458.

Integrative Biology and Infectious Diseases Branch
Dr. Lillian Shum
Phone: 301-594-0618
Email: shuml@nidcr.nih.gov 

Behavioral and Social Sciences Research Branch
Dr. Melissa Riddle
Phone: 301-451-3888
Email: riddleme@nidcr.nih.gov 

Translational Genomics Research Branch
Dr. Emily Harris
Phone: 301-594-4846
Email: harrisel@nidcr.nih.gov

Center for Clinical Research
Dr. Jane Atkinson
Phone: 301-435-7098
Email: jatkinso@nidcr.nih.gov

Division of Extramural Activities
Alicia Dombroski, Ph.D.
Phone: 301-594-4805
Email: adombroski@mail.nih.gov

The National Institute of Dental and Craniofacial Research (NIDCR) will not accept R03 applications in response to the Parent R03 FOA. The NIDCR uses the R03 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates. The currently active announcements are listed on the NIDCR website at: http://www.nidcr.nih.gov/GrantsAndFunding/Types_of_
Grants_Awarded_by_NIDCR/FundingMechanisms/

Hua-Chuan Sim, M.D.
Phone: 301- 594 4882
FAX: 301- 402-2952
E-mail: simh@mail.nih.gov

The National Library of Medicine (NLM) will not accept R03 applications in response to the Parent R03 FOA. NLM uses the R03 mechanism only when specified by specific PAs or RFAs that it has initiated or in which it participates.